NSECertificate under SEBI (Depositories and Participants) Regulations, 20181 Jul 2026 · 1 Jul 2026, 04:35 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Biofil Chemicals & Pharmaceuticals Limited · BIOFILCHEM
✦ AI SummaryResults
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
BIOFILCHEM_01072026163434_Regulation7401072026.pdf
View document text
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED
CIN: L24233MP1985PLC002709
Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.)
Tel. 0731-2426700; Email id- bcplcompliance@gmail.com;
Website- www.biofilgroup.net; Fax: 0731-2426700
To Date: 01st July,2026
The Secretary,
Corporate Relationship Department,
The BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400 001
The Company Secretary,
National Stock Exchange of India Limited,
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E) Mumbai – 400 051
Sub: Certificate under Regulation 74(5) of the Securities and Exchange Board of India
(Depository and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026
Ref: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Scrip Code: 524396; ISIN
No. : INE829A01014; SCRIP NAME: BIOFILCHEM)
Dear Sir/Madam,
With reference to the above captioned subject and pursuant to Regulation 74(5) of the
Securities and Exchange Board of India (Depository and Participants) Regulations, 2018, please
find enclosed herewith the confirmation certificate received from Ankit Consultancy Private
Limited, the Registrar and Share Transfer Agent of the Company for the quarter ended on 30th
June, 2026.
You are requested to please take on record the above said document for your reference and
further needful.
Thanking you,
Yours faithfully,
FOR, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED
APOORV JAIN
COMPANY SECRETARY & COMPLIANCE OFFICER
M. NO. A71739
ANKIT CONSULTANCY PVT LTD
(REGISTRAR AND SHARE TRANSFER AGENT)
60, ELECTRONIC COMPLEX, PARDESHIPURA, INDORE (MP)-452010
CIN No. : U74140MP1985PTC003074
PHONE NO.: 0731-4065799, 4065797
SEBI REGISTRATION No : INR 000000767
Email: investor@ankitonline.com Website:-www.ankitonline.com
S.No. 0 Date -01/07/2026
BIOFIL CHEMICALS & PHARMACEUTICALS
LIMITED
B/12-B,INDUSTRIAL ESTATE POLOGROUND
INDORE
MADHYA PRADESH 452015
Subject : Confirmation Certificate in the matter of Regulation 74 (5) of Securities and
Exchange Board of India (Depositories and Participants) Regulations, 2018.
Sir/Madam,
We hereby confirm that the securities received from the depository participants for dematerialization
during the quarter ended 30 June 2026, were confirmed (accepted/rejected) to the depositories by
us and that securities comprised in the said certificates have been listed on the stock exchanges
where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialization have been
mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in register of members as the registered owner within 15 days.
Thanking you,
For Ankit Consultancy Pvt.Ltd.,
CS Saurabh Maheshwari
(Compliance officer)